by Dr Christine Campbell, University of Edinburgh
Living with more than one long-term health condition (multi- morbidity) is common in Scotland. It is present in most people aged 65 years and older, and occurs 10–15 years earlier in people living in the most deprived areas. We suspect that multi-morbidity has the potential to affect many stages in the cancer care continuum, from participation in screening, recognition of potential signs and symptoms of cancer, suitability and response to treatment, and how long people survive.
This project is examining the impact of multi-morbidity on the cancer diagnostic pathway, treatment, and survivorship in Scotland for lung and colorectal cancer.
We are examining anonymised patient data from linked datasets from the Scottish Cancer Register, hospital records, prescribing data, the bowel screening programme and a national primary care database (SPIRE) to look for associations between multi-morbidity and participation in bowel screening, stage at cancer diagnosis, type of treatment given, and patient survival. We will look to see if there is any difference between men and women, by age group, and by level of deprivation.
Detailed information about how multi-morbidity impacts on the cancer journey of patients with lung and colorectal cancer in Scotland.
We are currently analysing the data and expect to have results by the end of 2017.
This issue has a brand new look and feel. We listened to feedback from our annual survey that indicated an appetite for more science in our newsletter (especially research taking place in Scotland), examples of good practice and more of a public health dimension. We have grouped these themes together and colour coded the science section orange for easy access.